Resolute Wealth Advisor’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.93K Buy
+350
New +$3.88K ﹤0.01% 346

Other funds holding CADL

Resolute Wealth Advisor's CADL Position: Q3 2026 in Review

Resolute Wealth Advisor opened a new position in Candel Therapeutics (CADL) in Q3 2026: 350 shares worth $2.93K. The stake represents ﹤0.01% of the portfolio and ranks #346 among its holdings.

141 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

  • Resolute Wealth Advisor held 350 shares of Candel Therapeutics worth $2.93K as of Q3 2026.
  • Candel Therapeutics was a new Resolute Wealth Advisor position in Q3 2026.
  • Candel Therapeutics made up ﹤0.01% of Resolute Wealth Advisor's portfolio in Q3 2026, its #346 holding.
  • 141 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Resolute Wealth Advisor's 13F filing for Q3 2026, filed 12 Nov 2026.